Recurring Fatigue After Biologic Administration:Patient-Reported Data from the Dutch Biologic Monitor

BACKGROUND: Fatigue is a common problem in immune-mediated inflammatory disease (IMID) patients, significantly impacting their quality of life. OBJECTIVES: In this study, we describe the pattern and characteristics of fatigue as a patient-reported adverse drug reaction (ADR) of biologics, and compared patient and treatment characteristics with patients reporting other ADRs or no ADRs. METHODS: In this cohort event monitoring study, the description and characteristics of fatigue reported as a possible ADR in the Dutch Biologic Monitor were assessed and analysed for commonly recurring themes or... Mehr ...

Verfasser: van Lint, Jette A
Jessurun, Naomi T
Tas, Sander W
Vonkeman, Harald E
van Doorn, Martijn B A
Hoentjen, Frank
Nurmohamed, Michael T
van Puijenbroek, Eugene P
van den Bemt, Bart J F
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Reihe/Periodikum: van Lint , J A , Jessurun , N T , Tas , S W , Vonkeman , H E , van Doorn , M B A , Hoentjen , F , Nurmohamed , M T , van Puijenbroek , E P & van den Bemt , B J F 2023 , ' Recurring Fatigue After Biologic Administration : Patient-Reported Data from the Dutch Biologic Monitor ' , Biodrugs , vol. 37 , no. 4 , pp. 541-550 . https://doi.org/10.1007/s40259-023-00592-8
Schlagwörter: Humans / Middle Aged / Quality of Life / Arthritis / Rheumatoid/drug therapy / Drug-Related Side Effects and Adverse Reactions / Fatigue/chemically induced / Adverse Drug Reaction Reporting Systems / Biological Products/adverse effects / Patient Reported Outcome Measures
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27445449
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://hdl.handle.net/11370/0f4140fe-e1d9-4419-afbc-4d82ed1fe5d6